NOXXON Pharma
GermanyWho owns NOXXON Pharma?
NOXXON Pharma is a German Biotech company, formerly owned by IBB Ventures and Sofinnova Partners, exited in 2018 (exit via IPO). No current private equity owner is on file.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Fully exited in 2018.
- ·Average hold across 2 realized cycles: 14 years.
Ownership history
2 ownership periods · co-invest detected
IBB Ventures took NOXXON Pharma public via IPO in 2018 after 20 years.
Sofinnova Partners took Noxxon Pharma public via IPO in 2016 after 8 years.
More from VC Fonds Technologie Berlin
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns NOXXON Pharma?
NOXXON Pharma was formerly owned by IBB Ventures and Sofinnova Partners, exited in 2018. No current private equity owner is on file.
Who has owned NOXXON Pharma over time?
NOXXON Pharma has been through 2 private-equity ownership periods: IBB Ventures · via VC Fonds Technologie Berlin · 1998–2018 · (IPO); Sofinnova Partners · via Sofinnova Capital VI · 2008–2016 · (IPO).